You might think ExxonMobil sounds like a better choice, but there's a caveat. While both are clear survivors, ExxonMobil's ...

Tonix prepares for the November 2025 launch of Tonmya with 3Q25 revenue growth, strong cash, higher SG&A, and a robust ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Geopolitical forecasting fails because global systems are inherently unpredictable. Business continuity plans (BCP) or crisis ...

Q1 2026 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsNicole JosephLeeAnn Rohmann - CEO, Chairman ...

These blue-chip companies have corrected over the past year but show improving fundamentals and clear earnings recovery potential in 2026.

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the ...

Founder of Satori Insights Matt King told CNBC’s Squawk Box Asia that the U.S. government shutdown has drained liquidity from the banking system, tightening the repo market. He warned the Fed may need ...

Mid-market CFOs caught in a modernization gap, Senate votes to end government shutdown, Starbucks union plans strike.

The military excels at what many organizations struggle with: aligning people, decisions and intent so that even under ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. TSLA: Risk or rebound?

Get the annual and quarterly balance sheet of BioCryst Pharmaceuticals, Inc. (BCRX) including details of assets, liabilities and shareholders' equity.